Zhou T - Search Results

1

Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients.

Monin MB, Baier LI, Gorny JG, Berger M, Zhou T, Mahn R, Sadeghlar F, Möhring C, Boesecke C, van Bremen K, Rockstroh JK, Strassburg CP, Eis-Hübinger AM, Schmid M, Gonzalez-Carmona MA. Monin MB, et al. Among authors: zhou t. Liver Cancer. 2023 May 10;12(4):339-355. doi: 10.1159/000529608. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901199 Free PMC article.

2

Genetic variants of UDP-glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis.

Weismüller TJ, Zhou T, Kalthoff S, Lenzen H, Manns MP, Strassburg CP. Weismüller TJ, et al. Among authors: zhou t. Liver Int. 2020 Jul;40(7):1645-1654. doi: 10.1111/liv.14487. Epub 2020 May 6. Liver Int. 2020. PMID: 32378294

3

[Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients].

Branchi V, Weismüller TJ, Zhou T, Henn J, Semaan A, Glowka TR, Gonzalez-Carmona M, Strassburg C, Kalff JC, Manekeller S, Matthaei H. Branchi V, et al. Among authors: zhou t. Chirurg. 2021 Feb;92(2):148-157. doi: 10.1007/s00104-020-01197-5. Chirurg. 2021. PMID: 32488382 Free PMC article. German.

4

Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.

Vogt A, Sadeghlar F, Ayub TH, Schneider C, Möhring C, Zhou T, Mahn R, Bartels A, Praktiknjo M, Kornek MT, Toma M, Schmidt-Wolf IGH, Branchi V, Matthaei H, Kalff JC, Strassburg CP, Gonzalez-Carmona MA. Vogt A, et al. Among authors: zhou t. Cancers (Basel). 2021 Jul 5;13(13):3375. doi: 10.3390/cancers13133375. Cancers (Basel). 2021. PMID: 34282787 Free PMC article.

5

Primary sclerosing cholangitis with moderately elevated serum-IgG4 - characterization and outcome of a distinct variant phenotype.

Zhou T, Lenzen H, Dold L, Bündgens B, Wedemeyer H, Manns MP, Gonzalez-Carmona MA, Strassburg CP, Weismüller TJ. Zhou T, et al. Liver Int. 2021 Dec;41(12):2924-2933. doi: 10.1111/liv.15028. Epub 2021 Aug 8. Liver Int. 2021. PMID: 34328259

6

New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?

Zhou T, Fronhoffs F, Dold L, Strassburg CP, Weismüller TJ. Zhou T, et al. J Hepatol. 2022 Jan;76(1):218-220. doi: 10.1016/j.jhep.2021.08.006. Epub 2021 Aug 25. J Hepatol. 2022. PMID: 34450237 Free PMC article. No abstract available.

7

Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes.

Mahn R, Sadeghlar F, Bartels A, Zhou T, Weismüller T, Kupczyk P, Meyer C, Gaertner FC, Toma M, Vilz T, Knipper P, Glowka T, Manekeller S, Kalff J, Strassburg CP, Gonzalez-Carmona MA. Mahn R, et al. Among authors: zhou t. Medicine (Baltimore). 2021 Sep 24;100(38):e27082. doi: 10.1097/MD.0000000000027082. Medicine (Baltimore). 2021. PMID: 34559100 Free PMC article.

8

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis.

Möhring C, Feder J, Mohr RU, Sadeghlar F, Bartels A, Mahn R, Zhou T, Marinova M, Feldmann G, Brossart P, von Websky M, Matthaei H, Manekeller S, Glowka T, Kalff JC, Weismüller TJ, Strassburg CP, Gonzalez-Carmona MA. Möhring C, et al. Among authors: zhou t. Front Oncol. 2021 Nov 10;11:717397. doi: 10.3389/fonc.2021.717397. eCollection 2021. Front Oncol. 2021. PMID: 34858809 Free PMC article.

9

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy.

Gonzalez-Carmona MA, Möhring C, Mahn R, Zhou T, Bartels A, Sadeghlar F, Bolch M, Vogt A, Kaczmarek DJ, Heling DJ, Dold L, Nattermann J, Branchi V, Matthaei H, Manekeller S, Kalff JC, Strassburg CP, Mohr RU, Weismüller TJ. Gonzalez-Carmona MA, et al. Among authors: zhou t. Sci Rep. 2022 Jan 19;12(1):1011. doi: 10.1038/s41598-021-04297-2. Sci Rep. 2022. PMID: 35046437 Free PMC article.

10

Impact on follow-up strategies in patients with primary sclerosing cholangitis.

Bergquist A, Weismüller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, Lytvyak E, Wunsch E, Milkiewicz P, Zenouzi R, Schramm C, Cazzagon N, Floreani A, Liby IF, Wiestler M, Wedemeyer H, Zhou T, Strassburg CP, Rigopoulou E, Dalekos G, Narasimman M, Verhelst X, Degroote H, Vesterhus M, Kremer AE, Bündgens B, Rorsman F, Nilsson E, Jørgensen KK, von Seth E, Cornillet Jeannin M, Nyhlin N, Martin H, Kechagias S, Wiencke K, Werner M, Beretta-Piccoli BT, Marzioni M, Isoniemi H, Arola J, Wefer A, Söderling J, Färkkilä M, Lenzen H; International PSC Study Group. Bergquist A, et al. Among authors: zhou t. Liver Int. 2023 Jan;43(1):127-138. doi: 10.1111/liv.15286. Epub 2022 May 16. Liver Int. 2023. PMID: 35535655 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,205 results

Search Page